| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |